文献速递肝病

肝细胞特异性缺失ATGL减轻饮食诱导的小鼠脂肪性肝炎

Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice.
PubMed 文献 · Hepatology · 2021-12-04

该研究在肝细胞特异性ATGL敲除小鼠中,给予MCD或HFHC饮食,发现尽管肝脏脂肪变性加重,但肝脏炎症和ER应激减轻,机制涉及PPARα活性降低和PPARδ活性增加;体外实验支持ATGL敲低可减轻炎症。提示抑制肝细胞脂解可能治疗脂肪性肝炎。

要点

  • 肝细胞ATGL缺失虽加重脂肪变性,但减轻饮食诱导的肝脏炎症和ER应激。
  • 机制涉及PPARα活性降低、PPARδ活性增加,PPARδ激动剂可抑制炎症。
  • ATGL敲低在HepG2细胞中减轻LPS/OP21诱导的炎症因子表达。

核心结论

  • 肝细胞ATGL/PNPLA2缺失可能通过增加PPARδ活性来对抗肝脏炎症和ER应激,尽管脂肪变性加重。
  • 抑制肝细胞脂解是治疗脂肪性肝炎的潜在策略。

研究设计与样本

  • 研究使用肝细胞特异性ATGL敲除(ATGL LKO)小鼠,给予甲硫氨酸-胆碱缺乏(MCD)或高脂高碳水化合物(HFHC)饮食。
  • 体外使用shRNA介导ATGL敲低的HepG2细胞,经LPS或油酸:棕榈酸2:1(OP21)处理。

主要发现

  • 与野生型小鼠相比,ATGL LKO小鼠在MCD和HFHC饮食后PPARα DNA结合活性降低,PPARδ DNA结合活性增加。
  • ATGL LKO小鼠组织学和生化上脂肪变性更明显,但肝脏炎症减轻,表现为Galectin3/MAC-2和髓过氧化物酶阳性细胞减少,IL-1β和F4/80 mRNA表达降低。
  • MCD饮食的ATGL LKO小鼠中ER应激标志物PERK和IRE1α蛋白水平降低。
  • PPARδ激动剂GW0742预处理抑制LPS处理的HepG2细胞中炎症标志物mRNA表达。
  • HepG2细胞中ATGL敲低减弱LPS/OP21诱导的CXCL5、CCL2和CCL5等促炎因子和趋化因子表达。

临床怎么用

  • 提示抑制肝细胞ATGL可能作为脂肪性肝炎的治疗策略,但尚需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Increased fatty acid (FA) flux from adipose tissue to the liver contributes to the development of NAFLD. Because free FAs are key lipotoxic triggers accelerating disease progression, inhibiting adipose triglyceride lipase (ATGL)/patatin-like phospholipase domain containing 2 (PNPLA2), the main enzyme driving lipolysis, may attenuate steatohepatitis. APPROACH AND RESULTS: Hepatocyte-specific ATGL knockout (ATGL LKO) mice were challenged with methionine-choline-deficient (MCD) or high-fat high-carbohydrate (HFHC) diet. Serum biochemistry, hepatic lipid content and liver histology were assessed. Mechanistically, hepatic gene and protein expression of lipid metabolism, inflammation, fibrosis, apoptosis, and endoplasmic reticulum (ER) stress markers were investigated. DNA binding activity for peroxisome proliferator-activated receptor (PPAR) α and PPARδ was measured. After short hairpin RNA-mediated ATGL knockdown, HepG2 cells were treated with lipopolysaccharide (LPS) or oleic acid:palmitic acid 2:1 (OP21) to explore the direct role of ATGL in inflammation in vitro. On MCD and HFHC challenge, ATGL LKO mice showed reduced PPARα and increased PPARδ DNA binding activity when compared with challenged wild-type (WT) mice. Despite histologically and biochemically pronounced hepatic steatosis, dietary-challenged ATGL LKO mice showed lower hepatic inflammation, reflected by the reduced number of Galectin3/MAC-2 and myeloperoxidase-positive cells and low mRNA expression levels of inflammatory markers (such as IL-1β and F4/80) when compared with WT mice. In line with this, protein levels of the ER stress markers protein kinase R-like endoplasmic reticulum kinase and inositol-requiring enzyme 1α were reduced in ATGL LKO mice fed with MCD diet. Accordingly, pretreatment of LPS-treated HepG2 cells with the PPARδ agonist GW0742 suppressed mRNA expression of inflammatory markers. Additionally, ATGL knockdown in HepG2 cells attenuated LPS/OP21-induced expression of proinflammatory cytokines and chemokines such as chemokine (C-X-C motif) ligand 5, chemokine (C-C motif) ligand (Ccl) 2, and Ccl5. CONCLUSIONS: Low hepatic lipolysis and increased PPARδ activity in ATGL/PNPLA2 deficiency may counteract hepatic inflammation and ER stress despite increased steatosis. Therefore, lowering hepatocyte lipolysis through ATGL inhibition represents a promising therapeutic strategy for the treatment of steatohepatitis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Fuchs CD, Radun R, Dixon ED, et al. Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice. Hepatology. 2021. PMID: 34387896. doi:10.1002/hep.32112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。